Literature DB >> 33693610

Impressive boosting of anti-S1/S2 IgG production in COVID-19-experienced patients after the first shot of the BNT162b2 mRNA COVID-19 Vaccine.

Amedeo F Capetti1, Carlo A Stangalini2, Fabio Borgonovo1, Davide Mileto3, Letizia Oreni4, Gianfranco Dedivitiis1, Angelica Lupo4, Maria V Cossu1, Lara Bilardo2, Andrea Giacomelli4, Massimo Galli4, Giuliano Rizzardini1,5.   

Abstract

Entities:  

Year:  2021        PMID： 33693610      PMCID： PMC7989538          DOI： 10.1093/cid/ciab214

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  2 in total

1.  Rapid lateral-flow immunochromatographic tests to assess anti N/S IgG seropositivity after BNT162b2 vaccine: A cross-sectional study: Rapid lateral-flow immunochromatographic tests after BNT162b2 vaccine.

Authors:  Laura Pezzati; Andrea Giacomelli; Davide Mileto; Federico Conti; Gloria Gagliardi; Alberto Rizzo; Laura Milazzo; Marco Schiuma; Alice Covizzi; Matteo Siano; Cinzia Bassoli; Matteo Passerini; Marco Piscaglia; Alessandro Torre; Letizia Oreni; Giuliano Rizzardini; Massimo Galli; Anna Lisa Ridolfo; Spinello Antinori
Journal:  J Infect       Date:  2021-05-29       Impact factor: 38.637

2.  COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants.

Authors:  Pinja Jalkanen; Pekka Kolehmainen; Hanni K Häkkinen; Moona Huttunen; Paula A Tähtinen; Rickard Lundberg; Sari Maljanen; Arttu Reinholm; Sisko Tauriainen; Sari H Pakkanen; Iris Levonen; Arttu Nousiainen; Taru Miller; Hanna Välimaa; Lauri Ivaska; Arja Pasternack; Rauno Naves; Olli Ritvos; Pamela Österlund; Suvi Kuivanen; Teemu Smura; Jussi Hepojoki; Olli Vapalahti; Johanna Lempainen; Laura Kakkola; Anu Kantele; Ilkka Julkunen
Journal:  Nat Commun       Date:  2021-06-28       Impact factor: 14.919
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.